ThyroidPrint®: Your partner in Precision Diagnostics.

Envisioned from 15 years of rigorous research at GeneproDX, ThyroidPrint® is our response to the crucial need for decisive diagnostics. We've woven together genomics and artificial intelligence, creating an unparalleled tool to elevate your diagnostic journey. With ThyroidPrint®, you gain a powerful ally in precision medicine, transforming patient care and achieving shared triumphs in the fight against indeterminate thyroid nodules. Join us in the patient care

Experience the ThyroidPrint® Difference

Simplicity and Versatility

Run ThyroidPrint® in your own hospital, or opt for the centralized model in our state-of-the-art laboratory.

Improve Patient Experience

Reduce unnecessary surgeries and the stress of uncertain results, dramatically improving the patient journey.

Partnership Opportunity

Joining forces with ThyroidPrint® gives you the chance to be part of a game-changing diagnostic approach.

Resolve Your
Uncertainty

ThyroidPrint® predicts whether an indeterminate thyroid nodule is benign or not with high diagnostic accuracy allowing to avoid diagnostic surgery.

GeneproDX presents ThyroidPrint®, a molecular diagnostic tool streamlining the management of indeterminate thyroid nodules (Bethesda III/IV). This fifteen year long research output redefines nodules as Benign or Malignancy Suspicious, boosting patient care decisions. GeneproDX® is accredited by College of American Pathologists (No. 1821095).

+1200

Test Performed

We are in 8 Countries

+67%

Surgeries Avoided

+300

Physicians

Scientific evidence

ThyroidPrint®, globally validated in hundreds of patients, including those from the USA, ensures consistent and top-quality results. We invite you to download and delve deeper into the studies that support our test, which have been recognized in reputable publications such as the Thyroid Journal. These studies demonstrate the rigorous scientific research and proven clinical value of our test.

Download

Biomarker Discovery & Development

This paper provides the insight on the biomarker discovery process and classifier development to reach a statistical performance necessary to serve the intended use of ThyroidPrint® (Rule-out).

Download

Test Design & Statistical Rational

This review addresses the statistical rational supporting the intended use of molecular testing for indeterminate thyroid nodules.

Download

Clinical Validation

This publication is reports two-independent multicenter – prospective trials that validate the clinical performance of ThyroidPrint® in two- ethnically diverse cohorts